FI
Formae, Inc.
StreetZero Signal 66
About Formae, Inc.
Formae, Inc. is a pioneering medical device company dedicated to transforming osteoarthritis management through innovative technology. Its flagship product, CyborGel Synthetic Cartilage Implant System, is an FDA designated Breakthrough Device engineered for minimally invasive implantation to relieve knee pain. The company focuses on arthroscopic joint resurfacing and biomimetic synthetic cartilage for early bone-on-bone osteoarthritis intervention.
LATEST FUNDINGCrowdfunding
$5.0M
Announced 2026-10-13
TOTAL RAISED$5M
IN THE NEWS
- 🔗 Formae 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- 🔗 Forma Raises $40 Million in Series B Funding
- 🔗 Forma Raises $40 Million in Series B Funding to Transform Employee Benefits for the Modern Workforce | Blog posts | Forma
- 🔗 Formae, Inc.
- 🔗 Formae - Products, Competitors, Financials, Employees, Headquarters Locations
EMPLOYEES—
FOUNDED—
HQVillanova, PA, USA
Industry
Crowdfunding
Tags
Medical DeviceHealthcareOsteoarthritis
Investors
Key highlights
- Developing CyborGel Synthetic Cartilage Implant System as FDA Breakthrough Device.
- Focuses on minimally invasive arthroscopic procedures for knee osteoarthritis.
- Received Unattributed VC funding from BioAdvance.
- Based in Villanova, PA with patent activity in implant instrumentation.
Ask StreetZero about Formae, Inc.
Put our AI to work on this deal.
Similar companies
Other Crowdfunding deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account